Our findings that high expression of SLC39A10 was associated with worse OS in patients with lymphoma-positive BC, but not correlated the OS in patients with lymphoma-negative BC suggested that SLC39A10 plays a vital role in metastatic BC. This evidence concerns the gene SLC39A10 and breast cancer.